These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1079955)

  • 41. In vitro synthesis of IgM rheumatoid factor by lymphocytes from patients with essential mixed cryoglobulinemia.
    Meroni PL; Barcellini W; Sinico RA; Fornasieri A; Sguotti C; Invernizzi F; D'Amico G; Zanussi C
    Clin Exp Immunol; 1986 Aug; 65(2):303-10. PubMed ID: 3491708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of B-lymphocyte function by T-lymphocytes in patients with advanced lung cancer.
    Venkataraman M; Rao DS; Levin RD; Westerman MP
    J Natl Cancer Inst; 1985 Jan; 74(1):37-41. PubMed ID: 3155815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
    Petersen J
    Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-DR positive T lymphocytes in blood and synovial fluid in rheumatoid arthritis.
    Kluin-Nelemans HC; van der Linden JA; Gmelig Meyling FH; Schuurman HJ
    J Rheumatol; 1984 Jun; 11(3):272-6. PubMed ID: 6610750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of normal lymphocyte transformation by plasma and lymphocyte factors in chronic lymphatic leukaemia.
    Tavadia HB; Goudie RB; Nicoll WD
    Clin Exp Immunol; 1974 Feb; 16(2):177-82. PubMed ID: 4549705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.
    Alarcón-Segovia D; Palacios R; Ibáñez de Kasep G
    J Clin Lab Immunol; 1981 May; 5(3):143-8. PubMed ID: 6453999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunologic similarities observed in the course of multiple sclerosis and systemic scleroderma].
    Czernicki J; Niedworok J; Onisk Z; Tchórzewski H
    Pol Tyg Lek; 1978 Feb; 33(9):337-40. PubMed ID: 652647
    [No Abstract]   [Full Text] [Related]  

  • 49. T-cell activation in the lungs of patients with systemic sclerosis and its relation with pulmonary fibrosis.
    Bresser P; Jansen HM; Weller FR; Lutter R; Out TA
    Chest; 2001 Jul; 120(1 Suppl):66S-68S. PubMed ID: 11451930
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical significance of lymphocyte responsiveness to scleroderma-inducing glycosaminoglycan-associated antigen in systemic scleroderma.
    Tamura T; Ishikawa H
    Dermatologica; 1985; 171(6):435-41. PubMed ID: 4092798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Characteristics of phytohemagglutinin reactivity of human lymphocytes].
    Onody K; Gyódi E; Varga M; Bojárszky K; Petrányi G
    Orv Hetil; 1977 Jun; 118(25):1457-60. PubMed ID: 301260
    [No Abstract]   [Full Text] [Related]  

  • 52. Lowered angiogeneic capability of peripheral blood lymphocytes in progressive systemic sclerosis (scleroderma).
    Kaminski MJ; Majewski S; Jablonska S; Pawinska M
    J Invest Dermatol; 1984 Mar; 82(3):239-43. PubMed ID: 6199433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scleroderma. A model for fibrosis.
    Fleischmajer R; Perlish JS; Duncan M
    Arch Dermatol; 1983 Dec; 119(12):957-62. PubMed ID: 6360053
    [No Abstract]   [Full Text] [Related]  

  • 54. Connective tissue diseases: Nucleosomes and systemic sclerosis.
    O'Reilly S; van Laar JM
    Nat Rev Rheumatol; 2016 Mar; 12(3):138-9. PubMed ID: 26841691
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunology in scleroderma.
    Barnett AJ
    Med J Aust; 1978 Aug; 2(4):138-40. PubMed ID: 310015
    [No Abstract]   [Full Text] [Related]  

  • 56. T-cell imbalance in progressive systemic sclerosis defined by monoclonal antibodies.
    Claudy AL; Le Petit JC; Barthelemy H; Garcier F
    Arch Dermatol Res; 1982; 274(1-2):189-92. PubMed ID: 6984640
    [No Abstract]   [Full Text] [Related]  

  • 57. Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.
    López-Cacho JM; Gallardo S; Posada M; Aguerri M; Calzada D; Mayayo T; González-Rodríguez ML; Rabasco AM; Lahoz C; Cárdaba B
    Biomed Res Int; 2014; 2014():148293. PubMed ID: 24818126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding the pathogenesis and developing new therapy of systemic sclerosis.
    Sato S
    J Dermatol; 2016 Jan; 43(1):9. PubMed ID: 26782001
    [No Abstract]   [Full Text] [Related]  

  • 59. B-cell epitopes of scleroderma-specific autoantigens.
    Verheijen R
    Mol Biol Rep; 1992 Jun; 16(3):183-9. PubMed ID: 1380642
    [No Abstract]   [Full Text] [Related]  

  • 60. Case history of a patient with multiple sclerosis and scleroderma.
    Jawad SH; Askari A; Ward AB
    Br J Rheumatol; 1997 Apr; 36(4):502-3. PubMed ID: 9159550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.